XML 29 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Class B Common Stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Non- Controlling Interest
Non- Controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
Secondary Offering and Redemption of Units
Secondary Offering and Redemption of Units
Common stock
Class A Common Stock
Secondary Offering and Redemption of Units
Common stock
Class B Common Stock
Secondary Offering and Redemption of Units
Additional Paid-In Capital
Beginning balance at Dec. 26, 2018 $ 273,455       $ 30 $ 8 $ 195,633 $ 30,404   $ 0   $ 47,380          
Beginning balance (in shares) at Dec. 26, 2018         29,520,833 7,557,347                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income 24,128             19,827       4,301          
Other comprehensive loss:                                  
Net unrealized losses related to available-for-sale securities 2                                
Net change in foreign currency translation adjustment 2                 2              
Equity-based compensation 7,700           7,700                    
Equity-based compensation 7,805       $ 0   4,517         3,288          
Activity under stock compensation (in shares)         484,319                        
Redemptions 0                     (11,934)   $ 0 $ (2) $ (2) $ (11,934)
Redemptions (in shares)         (1,721,887)                   (1,721,887) (1,721,887)  
Effect of GTC Merger         $ (3) $ (3) (19,218)         (19,218)          
Effect of GTC Merger (in shares)         (2,690,263) (2,690,263)                      
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis 5,408           5,408                    
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis (1,708)                     (1,708)          
Ending balance at Dec. 25, 2019 321,985 $ 5,195     $ 35 $ 3 244,410 54,367 $ 4,136 2 23,168 $ 1,059        
Ending balance (in shares) at Dec. 25, 2019         34,417,302 3,145,197                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (45,534)             (42,158)       (3,376)          
Other comprehensive loss:                                  
Net unrealized losses related to available-for-sale securities 1                                
Net change in foreign currency translation adjustment 1                 1              
Equity-based compensation 5,600           5,600                    
Equity-based compensation 6,215       $ 1   5,909         305          
Activity under stock compensation (in shares)         456,942                        
Redemptions                       (1,723)   0 $ 0 $ 0 (1,723)
Redemptions (in shares)         (194,009)                   (194,009) (194,009)  
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis 1,707           1,707                    
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis (478)                     (478)          
Equity offering (in shares)         3,649,537                        
Issuance of Class A common stock sold in equity offerings, net of underwriting discounts, commissions and offering costs 144,997       $ 3   135,718         9,276          
Ending balance at Dec. 30, 2020 434,493       $ 39 $ 3 395,067 12,209   3   27,172          
Ending balance (in shares) at Dec. 30, 2020     38,717,790 2,951,188 38,717,790 2,951,188                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income (10,111)             (8,655)       (1,456)          
Other comprehensive loss:                                  
Net unrealized losses related to available-for-sale securities (2)                                
Net change in foreign currency translation adjustment (2)                 (2)              
Equity-based compensation 8,803           8,803                    
Equity-based compensation 3,177       $ 0   1,829         1,348          
Activity under stock compensation (in shares)         395,006                        
Redemptions                       (33)   $ 0 $ 0 $ 0 $ (33)
Redemptions (in shares)         (29,601)                   (29,601) (29,601)  
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis 208           208                    
Establishment of liabilities under tax receivable agreement and related changes to deferred tax assets associated with increases in tax basis (968)                     (968)          
Ending balance at Dec. 29, 2021 $ 435,600       $ 39 $ 3 $ 405,940 $ 3,554   $ 1   $ 26,063          
Ending balance (in shares) at Dec. 29, 2021     39,142,397 2,921,587 39,142,397 2,921,587